FDA 483 - Christina S. Baik, M.D. - June 03, 2020

An FDA inspection of Christina S. Baik, M.D., a clinical investigator in Seattle, WA, revealed a significant deviation from an investigational plan. Specifically, a subject who met exclusion criteria was improperly enrolled and administered a study drug. This indicates a failure to adhere to study protocols and investigator responsibilities.